Maxillomandibular Advancement in the Treatment of Obstructive Sleep Apnea
Primary Purpose
OSA, OSAS, Apnea, Obstructive Sleep
Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Maxillomandibular advancement
monomaxillary surgery (isolated MaxS)
monomandibullary surgery (MandS)
Sponsored by
About this trial
This is an interventional treatment trial for OSA focused on measuring OSA, orthognathic surgery
Eligibility Criteria
Inclusion Criteria:
- Patients over 18 years of age who present any kind of dentofacial deformity candidates for orthognathic surgery treatment.
- Growth of the maxillofacial complex completed.
- Patients without uncontrolled cardio-pulmonary disease.
- Patients willing to understand the procedures of the study and that agree to give their signed informed consent.
- Patients who commit to perform the postoperative controls for at least one postoperative year.
- Patients with a good general condition of health, confirmed by pre-operative study and assessment by Anaesthesiology (ASA).
Exclusion Criteria:
- Patients with a clinical history in which any surgery would be contraindicated
- Patients with any facial Syndromic malformation
- Patients who have undergone chemotherapy or radiotherapy during the last 5 years, including area of head and neck.
- Patients who refuse to accept the clinical conditions of the study and are not willing to sign the form corresponding informed consent.
- Patients who are expected to lack adherence to follow-up or to the treatment.
- Treatment with bisphosphonates or Denosumab (Prolia®).
Sites / Locations
- Institute of Maxillofacial Surgery, Teknon Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
Bimaxillary surgery (MMA)
monomaxillary surgery (Isolated MaxS)
monomandibullary surgery (Isolated MandS)
Arm Description
Bimaxillary Orthognathic Surgery. MMA
Monomaxillary surgery (Isolated MaxS)
Monomandibular surgery (Isolated MandS)
Outcomes
Primary Outcome Measures
Upper airway volume change
Evaluation of volume change of the pharyngeal airway before (Day 0) and month (Month 1) and 12 months (Month 12) comparing the three-dimensional measurements of maxillary /bimaxillary surgery by conical beam computed tomography superposition. Cubic millimeters (mm^3 will be used to evaluate this outcome)
Secondary Outcome Measures
Pharyngeal airway space (amount of movement)
Evaluation of the amount of movement (pharyngeal airway space increase) before (Day 0) and month (Month 1) and 12 months (Month 12) comparing the three-dimensional measurements of maxillary /bimaxillary surgery by conical beam computed tomography superposition. Millimeters will be used to determine this outcome
Direction of movement (advancement or setback)
Evaluation of the direction of movement (advancement or setback) and its impact (negative/positive) in the total upper airway volume change, before (Day 0) and month (Month 1) and 12 months (Month 12) comparing the three-dimensional measurements of maxillary /bimaxillary surgery by conical beam computed tomography superposition. Millimetres will be used to determine this outcome.
Apnea-hypopnea index (AHI) assessment
Evaluation of clinical indicators of obstructive sleep apnea: Apnea-hypopnea index by polysomnography evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12). AHI scale: Mild OSA 5-15/ moderate OSA: 15-30/ severe OSA: >30 events/hour. A higher score means a worse outcome.
Blood pressure changes
Evaluation of clinical indicators of obstructive sleep apnea: blood pressure change evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12). Systolic and diastolic pressures will be both recorded. Mean cardiac frequency will be obtained.
Evaluation of clinical indicators of obstructive sleep apnea: blood pressure change evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12). Systolic and diastolic pressures will be both recorded. Mean cardiac frequency will be obtained.
Evaluation of clinical indicators of obstructive sleep apnea: blood pressure change evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12). Systolic and diastolic pressures will be both recorded. Mean cardiac frequency will be obtained. Assessed in mm Hg
Body mass index (BMI)
Evaluation of Body mass index (e.g., weight in kilograms, height in m) change before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12). (e.g., weight and height will be combined to report BMI in kg/m^2).
Lowest oxygen saturation 90% (LSat 90%)
Evaluation of clinical indicators of obstructive sleep apnea: lowest oxygen saturation (90%) change evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12).
Epworth sleepiness scale test (ESS)
The Epworth Sleepiness Scale (ESS) is a scale intended to measure daytime sleepiness that is measured by use of a very short questionnaire. Used clinically to screen for the manifestations of the behavioral morbidity associated to obstructive sleep apnea, first used by Johns, 1991.
The ESS asks people to rate, on a four-point scale, their usual chances of falling asleep in eight different situations. These must be answered beyond 4 punctuations ranges depending on: 0 = would never doze, 1 = slight chance of dozing, 2 = moderate chance of dozing or 3 = high chance of dozing. The total ESS score is the sum of item-scores and ranges between 0 and 24; the higher the score, the higher the person's level sleepines. A score of 10-12 is suggested as the cutoff among clinic populations being screened for a sleep disorder.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03796078
Brief Title
Maxillomandibular Advancement in the Treatment of Obstructive Sleep Apnea
Official Title
Impact of Maxillomandibular Advancement Upon the Pharyngeal Airway Volume and the Apnea-hypopnea Index in the Treatment of Obstructive Sleep Apnea
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 30, 2018 (Actual)
Primary Completion Date
January 1, 2024 (Anticipated)
Study Completion Date
December 1, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Centro Medico Teknon
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
ABSTRACT OBJECTIVES: To study the correlation between pharyngeal airway volume (PAV), the clinical indicators of obstructive sleep apnea (AHI, ESS), and the impact of orthognathic surgery on them.
METHODS: A prospective, descriptive, unicentric study carried out by a multidisciplinary team to evaluate the following parameters in patients undergoing orthognathic surgery at Maxillofacial institute Teknon medical center.
During the study period:
Record of the type, magnitude and direction of surgical movements of the maxillofacial complex made during the surgery (Day 0-Month 1).
Assessment of PAS/PAV stability (relapse) at short term (1 month).
3D PAV assessment by cranial voxel-based superimposition protocol before and one month and 12 months after orthognathic surgery.
Household polysomnography (PSG) registry/ apnea-hypopnea index (Day 0, Month 1 and Month 12). (AHI evaluation bu neurophysiologist)
Assessment of the clinical indicators of obstructive sleep apnea at day 0, month 1 and month 12:, blood pressure (mm Hg) , and daytime hypersomnia test (Epworth sleepiness scale, ESS) (Day 0, Month 1 and Month 12).
Record of body mass index (BMI) (cm/Kg2)
Main Objective:
• Evaluate the impact of orthognathic surgery (bimaxillary or monomaxillary) and its movements on the PAV and the clinical indicators of OSA.
Specific objectives:
• Interrelate the degree of dentofacial deformity with the IAH.
Study the potential correlation between the volume of the VAS and the IAH.
Correlate the type, direction and magnitude of the surgical movements of the maxillofacial complex with PAV/PAS increase Correlate the type, direction and magnitude of the surgical movements of the maxillofacial complex with the cure of OSA (household PSG AHI assessment) and the following clinical indicators of OSA: diurnal hypersomnia test (ESD, ESS).
Evaluate negative effects of either maxillary or mandibular surgical movements in PAS/PAV increase and the cures of OSA.
Evaluate negative effects of either maxillary or mandibular surgical movements in the improvement of the clinical symptoms and the cure of OSA.
To study the possible effect of surgical complications on PAS/PAV stability at long term and the clinical symptoms of OSA.
Demonstrate that maxillomandibular surgery is a defined, predictable and a definitive cure for OSA.
Demonstrate that skeletal, linear, and cross-sectional volume parameters remain stable at long-term.
Demonstrate that AHI and OSA-related parameters stay stable at long term after mono- or bimaxillary surgery.
Hypothesis
H1a: Maxillomandibular advancement (orthognathic surgery) does correlate with the volume of the upper airway, at both short or long term.
H2a: Maxillomandibular advancement (orthognathic surgery) does correlate with the clinical indicators of obstructive sleep apnea, at both short or long term.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
OSA, OSAS, Apnea, Obstructive Sleep, Orthognathic Surgery
Keywords
OSA, orthognathic surgery
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
80 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Bimaxillary surgery (MMA)
Arm Type
Active Comparator
Arm Description
Bimaxillary Orthognathic Surgery. MMA
Arm Title
monomaxillary surgery (Isolated MaxS)
Arm Type
Active Comparator
Arm Description
Monomaxillary surgery (Isolated MaxS)
Arm Title
monomandibullary surgery (Isolated MandS)
Arm Type
Active Comparator
Arm Description
Monomandibular surgery (Isolated MandS)
Intervention Type
Procedure
Intervention Name(s)
Maxillomandibular advancement
Other Intervention Name(s)
MMA (maxillomandibular advancement)
Intervention Description
Treatment: Mono or Bimaxillary Orthognathic Surgery. The surgery of Reposition of the jaws is carried out under general anesthesia using minimally invasive techniques, the patient is extubated After surgery, antibiotics are prescribed during admission, anti-inflammatories, antiemetics and a local cold mask is applied of closed circuit at 17ºCelsius. The patient is discharged at 24 h.
Intervention Type
Procedure
Intervention Name(s)
monomaxillary surgery (isolated MaxS)
Intervention Description
Monomaxillary surgery (Isolated MaxS): The surgery of Reposition of the maxilla is carried out under general anesthesia using minimally invasive techniques, the patient is extubated After surgery, antibiotics are prescribed during admission, anti-inflammatories, antiemetics and a local cold mask is applied of closed circuit at 17ºCelsius. The patient is discharged at 24 h.
Intervention Type
Procedure
Intervention Name(s)
monomandibullary surgery (MandS)
Intervention Description
Monomandibullary surgery (Isolated MandS): The surgery of Reposition of the maxilla is carried out under general anesthesia using minimally invasive techniques, the patient is extubated After surgery, antibiotics are prescribed during admission, anti-inflammatories, antiemetics and a local cold mask is applied of closed circuit at 17ºCelsius. The patient is discharged at 24 h.
Primary Outcome Measure Information:
Title
Upper airway volume change
Description
Evaluation of volume change of the pharyngeal airway before (Day 0) and month (Month 1) and 12 months (Month 12) comparing the three-dimensional measurements of maxillary /bimaxillary surgery by conical beam computed tomography superposition. Cubic millimeters (mm^3 will be used to evaluate this outcome)
Time Frame
Evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12).
Secondary Outcome Measure Information:
Title
Pharyngeal airway space (amount of movement)
Description
Evaluation of the amount of movement (pharyngeal airway space increase) before (Day 0) and month (Month 1) and 12 months (Month 12) comparing the three-dimensional measurements of maxillary /bimaxillary surgery by conical beam computed tomography superposition. Millimeters will be used to determine this outcome
Time Frame
Evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12).
Title
Direction of movement (advancement or setback)
Description
Evaluation of the direction of movement (advancement or setback) and its impact (negative/positive) in the total upper airway volume change, before (Day 0) and month (Month 1) and 12 months (Month 12) comparing the three-dimensional measurements of maxillary /bimaxillary surgery by conical beam computed tomography superposition. Millimetres will be used to determine this outcome.
Time Frame
Evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12).
Title
Apnea-hypopnea index (AHI) assessment
Description
Evaluation of clinical indicators of obstructive sleep apnea: Apnea-hypopnea index by polysomnography evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12). AHI scale: Mild OSA 5-15/ moderate OSA: 15-30/ severe OSA: >30 events/hour. A higher score means a worse outcome.
Time Frame
Evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12).
Title
Blood pressure changes
Description
Evaluation of clinical indicators of obstructive sleep apnea: blood pressure change evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12). Systolic and diastolic pressures will be both recorded. Mean cardiac frequency will be obtained.
Evaluation of clinical indicators of obstructive sleep apnea: blood pressure change evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12). Systolic and diastolic pressures will be both recorded. Mean cardiac frequency will be obtained.
Evaluation of clinical indicators of obstructive sleep apnea: blood pressure change evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12). Systolic and diastolic pressures will be both recorded. Mean cardiac frequency will be obtained. Assessed in mm Hg
Time Frame
Evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12).
Title
Body mass index (BMI)
Description
Evaluation of Body mass index (e.g., weight in kilograms, height in m) change before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12). (e.g., weight and height will be combined to report BMI in kg/m^2).
Time Frame
Evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12).
Title
Lowest oxygen saturation 90% (LSat 90%)
Description
Evaluation of clinical indicators of obstructive sleep apnea: lowest oxygen saturation (90%) change evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12).
Time Frame
Evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12).
Title
Epworth sleepiness scale test (ESS)
Description
The Epworth Sleepiness Scale (ESS) is a scale intended to measure daytime sleepiness that is measured by use of a very short questionnaire. Used clinically to screen for the manifestations of the behavioral morbidity associated to obstructive sleep apnea, first used by Johns, 1991.
The ESS asks people to rate, on a four-point scale, their usual chances of falling asleep in eight different situations. These must be answered beyond 4 punctuations ranges depending on: 0 = would never doze, 1 = slight chance of dozing, 2 = moderate chance of dozing or 3 = high chance of dozing. The total ESS score is the sum of item-scores and ranges between 0 and 24; the higher the score, the higher the person's level sleepines. A score of 10-12 is suggested as the cutoff among clinic populations being screened for a sleep disorder.
Time Frame
Evaluated before surgery (Day 0), 1 month after surgery (Month 1) and 12 months after surgery (Month 12).
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients over 18 years of age who present any kind of dentofacial deformity candidates for orthognathic surgery treatment.
Growth of the maxillofacial complex completed.
Patients without uncontrolled cardio-pulmonary disease.
Patients willing to understand the procedures of the study and that agree to give their signed informed consent.
Patients who commit to perform the postoperative controls for at least one postoperative year.
Patients with a good general condition of health, confirmed by pre-operative study and assessment by Anaesthesiology (ASA).
Exclusion Criteria:
Patients with a clinical history in which any surgery would be contraindicated
Patients with any facial Syndromic malformation
Patients who have undergone chemotherapy or radiotherapy during the last 5 years, including area of head and neck.
Patients who refuse to accept the clinical conditions of the study and are not willing to sign the form corresponding informed consent.
Patients who are expected to lack adherence to follow-up or to the treatment.
Treatment with bisphosphonates or Denosumab (Prolia®).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Maria Giralt-Hernando, PhD
Phone
+34933 933 185
Ext
112
Email
mgiralt@uic.es
First Name & Middle Initial & Last Name or Official Title & Degree
Adaia Valls-Ontañón, PhD
Phone
+34933 933 185
Ext
112
Email
avalls@institutomaxilofacial.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Federico Hernández-Alfaro, PhD
Organizational Affiliation
Institute of Maxillofacial Surgery, Teknon Medical Center
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Adaia Valls-Ontañón, PhD
Organizational Affiliation
Institute of Maxillofacial Surgery, Teknon Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institute of Maxillofacial Surgery, Teknon Medical Center
City
Barcelona
ZIP/Postal Code
08022
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maria Giralt-Hernando, MSC
Phone
+34933 933 185
Ext
112
First Name & Middle Initial & Last Name & Degree
Adaia Valls-Ontañón, PhD
Phone
+34933 933 185
Ext
112
Email
avalls@institutomaxilofacial.com
First Name & Middle Initial & Last Name & Degree
Federico Hernández-Alfaro, PhD
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
31673361
Citation
Giralt-Hernando M, Valls-Ontanon A, Guijarro-Martinez R, Masia-Gridilla J, Hernandez-Alfaro F. Impact of surgical maxillomandibular advancement upon pharyngeal airway volume and the apnoea-hypopnoea index in the treatment of obstructive sleep apnoea: systematic review and meta-analysis. BMJ Open Respir Res. 2019 Oct 9;6(1):e000402. doi: 10.1136/bmjresp-2019-000402. eCollection 2019.
Results Reference
background
PubMed Identifier
33171114
Citation
Giralt-Hernando M, Valls-Ontanon A, Haas Junior OL, Masia-Gridilla J, Hernandez-Alfaro F. What are the Surgical Movements in Orthognathic Surgery That Most Affect the Upper Airways? A Three-Dimensional Analysis. J Oral Maxillofac Surg. 2021 Feb;79(2):450-462. doi: 10.1016/j.joms.2020.10.017. Epub 2020 Oct 15.
Results Reference
background
PubMed Identifier
33632574
Citation
Hernandez-Alfaro F, Giralt-Hernando M, Brabyn PJ, Haas OL Jr, Valls-Ontanon A. Variation between natural head orientation and Frankfort horizontal planes in orthognathic surgery patients: 187 consecutive cases. Int J Oral Maxillofac Surg. 2021 Sep;50(9):1226-1232. doi: 10.1016/j.ijom.2021.02.011. Epub 2021 Feb 22.
Results Reference
background
Learn more about this trial
Maxillomandibular Advancement in the Treatment of Obstructive Sleep Apnea
We'll reach out to this number within 24 hrs